Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2
about
Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: relation to their biological functionsPhytomelatonin: assisting plants to survive and thriveThe structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)Synthesis of Casimiroin and Optimization of Its Quinone Reductase 2 and Aromatase Inhibitory ActivitiesMechanism-Based Inhibition of Quinone Reductase 2 (NQO2): Selectivity for NQO2 over NQO1 and Structural Basis for Flavoprotein InhibitionX-ray structural studies of quinone reductase 2 nanomolar range inhibitorsDesign, Synthesis, and Biological Evaluation of Potent Quinoline and Pyrroloquinoline Ammosamide Analogues as Inhibitors of Quinone Reductase 2Isolation and evaluation of kaempferol glycosides from the fern Neocheiropteris palmatopedata.Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.Chloroquine binding reveals flavin redox switch function of quinone reductase 2.Potential chemopreventive agents based on the structure of the lead compound 2-bromo-1-hydroxyphenazine, isolated from Streptomyces species, strain CNS284Precursor-Directed Generation of Amidine Containing Ammosamide Analogs: Ammosamides E-PScreening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MSBioactive compounds from the fern Lepisorus contortusCis-trans peptide variations in structurally similar proteinsMelatonin receptors, heterodimerization, signal transduction and binding sites: what's new?Resveratrol: Biological and pharmaceutical properties as anticancer molecule.Quinone reductase 2 is a catechol quinone reductaseCrystal Structure of Hyp-1, a Hypericum perforatum PR-10 Protein, in Complex with Melatonin.Melatonin and cancer: current knowledge and its application to oral cavity tumours.Synthetic melatoninergic ligands: achievements and prospects.Quinone reductase 2 as a promising target of melatonin therapeutic actions.Anticancer Activity of Stilbene-Based Derivatives.The two common polymorphic forms of human NRH-quinone oxidoreductase 2 (NQO2) have different biochemical properties.Melatonin receptor agonist-induced reduction of SNP-released nitric oxide and cGMP production in isolated human non-pigmented ciliary epithelial cells.Role of Quinone Reductase 2 in the Antimalarial Properties of Indolone-Type Derivatives.Evidence for NQO1 and NQO2 catalyzed reduction of ortho- and para-quinone methides.NQO2:FAD dimer reduces quinones to hydroquinonesEight hours of nocturnal 915 MHz radiofrequency identification (RFID) exposure reduces urinary levels of melatonin and its metabolite via pineal arylalkylamine N-acetyltransferase activity in male rats.
P2860
Q22305604-F2D3F0F9-3A80-4669-A0D4-204DDA372417Q26824170-00005839-E2E5-439B-8B69-D2E2E588AEABQ27653890-5CDA46EC-F0F3-4627-B78A-304496845609Q27654021-11B86453-DB9F-43B7-AC8D-A598E6092551Q27667472-AFF2D8F4-1562-4889-8AD5-0F67DD3F8B94Q27667662-1DA569B2-32D5-40CD-A0A9-C6DDD7F49D89Q27676483-0D130D87-7C88-4FFC-852B-67FF622AC5DCQ33837074-39DB3202-3FD6-439F-807B-D4506908E29EQ33992426-46D4D715-BF95-4758-BCD0-3F13776537E6Q34331796-D3B1DCEC-66BD-4A64-9B2F-3385659008CEQ34440701-D91756EF-18D9-4188-AC19-1A81BF4FD11DQ34500926-6BF6FDFF-6C41-4DF9-A2F9-BB57BE0457D1Q34555612-833C39B3-69A8-47C3-9C9E-BC4880A6258FQ34749866-5D306A4B-A10B-41CB-804B-740E8871614DQ36719015-D94CC28D-F192-4F3D-B432-5F61D8416268Q36790172-2F7F3E47-72DB-49F0-9571-F74C28AA3FC9Q36848141-F5066BF1-FDA7-4511-BCEB-411060CAFD4BQ36856168-2A53F09E-9AA9-4AC2-B36E-5D079A723D09Q36911514-451BBE8A-EF5B-4D85-B62E-66FCFE0F96CBQ37834066-3D05A120-CAF3-4EF1-8381-48643F9EFCCCQ38457000-A48591B6-EFC8-4686-85B6-2EE312A5C198Q38606734-C61E55CC-9B90-482D-80DB-789D9E3F65B9Q39165544-810E9DE4-1634-4F53-AF92-728C92B7137DQ40296515-5DE73C84-AE4F-4ECA-A192-49063DE766AFQ41768470-79418938-91BE-428D-A060-7E4C29B5CC40Q41913490-E35F0839-ADB8-41CD-BA1C-A49EE3734A9DQ46402017-1F16263B-878A-402A-B1E1-CEFD7BDD04F5Q50295344-EA73533B-61F0-42EF-9932-7BA5C51FB30DQ51841357-418D09CE-DC0F-4742-AD2F-698AC04C26BD
P2860
Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@ast
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@en
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@nl
type
label
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@ast
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@en
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@nl
prefLabel
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@ast
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@en
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@nl
P2860
P921
P3181
P356
P1433
P1476
Kinetic, thermodynamic and X-r ...... ogues with quinone reductase 2
@en
P2093
Barbara Calamini
Bernard D Santarsiero
P2860
P3181
P356
10.1042/BJ20071373
P407
P577
2008-07-01T00:00:00Z